PRAM1 antibody [C3], C-term

Eine Lieferung in diese Region ist nicht möglich.

SKU:: GTX108042
Zusätzliche Namen:: PML-RARA regulated adaptor molecule 1 , PML-RAR , PRAM-1
Anwendung:: WB, IHC-P
Konzentration:: 0.5 mg/ml
Physischer Zustand:: Liquid
Spezies-Reaktivität:: Human
Aufreinigung:: Affinity Purified
Lagerbedingungen:: -20[o]C Aliquot. Avoid freeze/thaw cycles. Store undiluted., 2-8[o]C Aliquot. Avoid freeze/thaw cycles. Store undiluted., -20[o]C/-70[o]C Aliquot. Avoid freeze/thaw cycles. Store undiluted.
Hersteller:: Genetex
Host:: Rabbit
Reaktivitäten:: Human
Buffer:: 0.1M Tris, 0.1M Glycine, 10% Glycerol, 0.01% Thimerosal.
Immunogen:: Carrier-protein conjugated synthetic peptide encompassing a sequence within the C-terminus region of human PRAM1. The exact sequence is proprietary.
Klon:: C3
Uniprot:: Q96QH2
Synonyme:: PML-RAR;PML-RARA target gene encoding an Adaptor Molecule-1;PML-RARA-regulated adapter molecule 1;PRAM;PRAM-1
Weitere Details:: The protein encoded by this gene is similar to FYN binding protein (FYB/SLAP-130), an adaptor protein involved in T cell receptor mediated signaling. This gene is expressed and regulated during normal myelopoiesis. The expression of this gene is induced by retinoic acid and is inhibited by the expression of PML-RARalpha, a fusion protein of promyelocytic leukemia (PML) and the retinoic acid receptor-alpha (RARalpha). [provided by RefSeq]